Companies / Atavistik Bio
Atavistik Bio
Cambridge, MA, United States
Atavistik Bio is a clinical-stage biotechnology company developing innovative therapies for patients with serious hematologic diseases.
Atavistik Bio, based in Cambridge, MA, United States, has 5 investors on file, among them Lux Capital, Nextech Invest and RA Capital. Its latest round on record is Series B, 5 Mar 2026, of 2 rounds. Its site was last checked 12 Nov 2026: site answers.
Funding
2 rounds on recordRound sizes and total raised are on Fundup AI, our sister product for funding data.
Investors
5 investors on file| Investor | Evidence | Type |
|---|---|---|
| Page + round | Venture capital | |
| Page + round | Venture capital | |
| Page + round | Venture capital | |
| Portfolio page | Corporate VC | |
| Page + round | Venture capital |
A company is shown only after its own site answers and carries its name. Sites are checked again on a schedule, because domains lapse and get bought. Round stages and dates come from Fundup AI; investor links come from portfolio pages and rounds; other facts name their source when you point at them. How we grade the data
Get Atavistik Bio and its investors as data
Look up any company's investors, or any investor's full portfolio, through one API key or MCP. A free account also opens Ask AI searches and alerts when Lux Capital adds a company.
Work email, sign-in link by email. Already have an account? Log in- Ask AI5 plain-English investor searches a day
- Full listsEvery portfolio row and two-firm overlap
- API and MCP100 REST or MCP calls a month, one key
- AlertsFollow 5 investors for portfolio and fund changes
$ curl -H "X-API-Key: YOUR_KEY" \
https://api.vcinfo.io/v1/companies/atavistikbio.com/investors
# also
GET /v1/companies/atavistikbio.com
GET /v1/companies/atavistikbio.com/news